We will focus on TOP2 poison associated t-AL, starting with the mechanism of action of TOP2 and TOP2 poisons and leading on to recent discoveries in topoisomerase biology that are relevant to the etiology of therapy-related secondary leukemia. This evidence concerns the gene TOP2A and leukemia.